Enriched environment promotes post-stroke neurogenesis through NF-κB-mediated secretion of IL-17A from astrocytes

Brain Res. 2018 May 15:1687:20-31. doi: 10.1016/j.brainres.2018.02.030. Epub 2018 Feb 23.

Abstract

Enriched environment (EE) has been shown to promote post-stroke neurogenesis and functional recovery. However, the underlying molecular mechanisms remains poorly understood. Male C57BL/6 mice underwent 60-min middle cerebral artery occlusion (MCAO) followed by reperfusion, after which mice were housed in either standard environment (SE) or EE. We found that post-ischemic EE exhibited reduced protein level of nuclear factor κB (NF-κB)/p65 in cytoplasm and increased its expression correspondingly in nucleus at 28 days post-ischemia (dpi). However, post-ischemic EE had no effects on terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL)-positive cells in ischemic hemisphere at 28dpi. EE mice treated with NF-kB inhibitor Bay11-7082 had decreased subventricular zone (SVZ) neural precursor cells (NPCs) proliferation, neuronal differentiation and subsequent functional recovery after stroke at 28dpi. Bay11-7082 treatment attenuated the promoting effects of post-ischemic EE on interleukin 17A (IL-17A) messenger RNA (mRNA) and protein expression at 28dpi. Furthermore, our in vitro data revealed that in primary astrocyte cultures addition of Bay11-7082 markedly decreased the expression of IL-17A in both the cell lysate and culture supernatant of activated astrocytes. Blockade of IL-17A with neutralizing antibody abrogated the promoting role of EE in NPCs proliferation derived from SVZ, neuronal differentiation and subsequent functional recovery after stroke. Thus, our results reveal a previously uncharacterized property of NF-κB/IL-17A signaling pathway in EE-mediated neurogenesis and functional recovery after ischemic stroke.

Keywords: Astrocytes; Environmental enrichment; IL-17A; Ischemic stroke; Nuclear factor kappa B.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / physiology
  • Astrocytes / metabolism*
  • Bromodeoxyuridine / metabolism
  • Disease Models, Animal
  • Doublecortin Domain Proteins
  • Environment*
  • Gene Expression Regulation / physiology
  • Infarction, Middle Cerebral Artery / nursing*
  • Infarction, Middle Cerebral Artery / pathology
  • Interleukin-17 / genetics
  • Interleukin-17 / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microtubule-Associated Proteins / metabolism
  • Motor Activity
  • NF-kappa B / metabolism*
  • Neurogenesis / drug effects
  • Neurogenesis / physiology*
  • Neuropeptides / metabolism
  • Nitriles / pharmacology
  • Protein Transport / physiology
  • RNA, Messenger
  • Sulfones / pharmacology
  • Time Factors

Substances

  • 3-(4-methylphenylsulfonyl)-2-propenenitrile
  • Doublecortin Domain Proteins
  • Interleukin-17
  • Microtubule-Associated Proteins
  • NF-kappa B
  • Neuropeptides
  • Nitriles
  • RNA, Messenger
  • Sulfones
  • Bromodeoxyuridine